thymic-factor--circulating and Burkitt-Lymphoma

Conditions for the reproducible measurement of thymic hormonal effect on the functional activity of human peripheral blood lymphocytes (PBL) were determined using a mixed lymphocyte-tumor culture assay. Three thymic hormonal preparations (thymopoietin, thymic humoral factor and TP-1) were tested by this assay and found to have a significant enhancing effect on the blastogenic response. Essential for the demonstration of the hormonal effect was the selection of suboptimal stimulation conditions, with the appropriate cell lines, including the number of stimulating cells and the time in culture. The most reproducible results were achieved when 1 x 10(5) PBL were co-cultured for 4 days with 1 x 10(4) mitomycin-C treated Raji lymphoma cells, after 1 h preincubation with one of the thymic preparations. However, strong enhancing effects of the thymic preparations could also be demonstrated with other tumor cel lines, especially IgR3 melanoma cells.

Topics: Adenocarcinoma; Burkitt Lymphoma; Carcinoma; Cell Line; Cells, Cultured; Colonic Neoplasms; Dose-Response Relationship, Drug; Female; Humans; Lymphocyte Activation; Lymphocytes; Melanoma; Thymic Factor, Circulating; Thymopoietins; Thymus Extracts; Thymus Hormones; Uterine Neoplasms